NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 87 filers reported holding NATERA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $81,894,487 | +89.6% | 756,252 | +60.2% | 0.05% | +79.3% |
Q1 2024 | $43,182,575 | +223.9% | 472,147 | +121.9% | 0.03% | +190.0% |
Q4 2023 | $13,330,481 | +7.5% | 212,811 | -30.2% | 0.01% | +11.1% |
Q1 2022 | $12,398,000 | -78.9% | 304,768 | -51.6% | 0.01% | -75.7% |
Q4 2021 | $58,799,000 | -17.5% | 629,603 | -1.5% | 0.04% | -19.6% |
Q3 2021 | $71,265,000 | +0.7% | 639,492 | +2.6% | 0.05% | -2.1% |
Q2 2021 | $70,786,000 | -38.7% | 623,502 | -45.2% | 0.05% | -44.0% |
Q1 2021 | $115,440,000 | -33.3% | 1,136,896 | -34.6% | 0.08% | -31.7% |
Q4 2020 | $172,985,000 | +12.7% | 1,738,195 | -18.2% | 0.12% | 0.0% |
Q3 2020 | $153,465,000 | +31.0% | 2,124,371 | -9.6% | 0.12% | +16.0% |
Q2 2020 | $117,107,000 | +67.3% | 2,348,726 | +0.2% | 0.11% | +24.7% |
Q1 2020 | $69,989,000 | -18.0% | 2,343,918 | -7.4% | 0.08% | -1.2% |
Q4 2019 | $85,315,000 | -15.7% | 2,532,355 | -18.0% | 0.09% | -19.6% |
Q3 2019 | $101,248,000 | -17.2% | 3,086,827 | -30.4% | 0.11% | -11.6% |
Q2 2019 | $122,310,000 | +66.4% | 4,434,727 | +24.4% | 0.12% | +65.8% |
Q1 2019 | $73,517,000 | +42.1% | 3,565,307 | -3.8% | 0.07% | +25.9% |
Q4 2018 | $51,748,000 | -40.6% | 3,706,873 | +1.8% | 0.06% | -27.5% |
Q3 2018 | $87,186,000 | +77.0% | 3,641,848 | +39.1% | 0.08% | +66.7% |
Q2 2018 | $49,264,000 | +105.9% | 2,617,623 | +1.4% | 0.05% | +100.0% |
Q1 2018 | $23,924,000 | +14.0% | 2,580,747 | +10.5% | 0.02% | +14.3% |
Q4 2017 | $20,992,000 | -30.8% | 2,335,091 | -0.7% | 0.02% | -32.3% |
Q3 2017 | $30,315,000 | +18.5% | 2,351,807 | -0.2% | 0.03% | +14.8% |
Q2 2017 | $25,590,000 | +23.7% | 2,356,346 | +1.0% | 0.03% | +22.7% |
Q1 2017 | $20,693,000 | +76.7% | 2,332,873 | +133.3% | 0.02% | +69.2% |
Q4 2016 | $11,708,000 | +5.6% | 999,823 | +0.2% | 0.01% | +8.3% |
Q3 2016 | $11,084,000 | -12.6% | 997,691 | -5.0% | 0.01% | -14.3% |
Q2 2016 | $12,677,000 | +26.6% | 1,050,731 | -0.1% | 0.01% | +27.3% |
Q1 2016 | $10,010,000 | -15.8% | 1,051,463 | -4.5% | 0.01% | -8.3% |
Q4 2015 | $11,889,000 | -3.3% | 1,100,862 | -3.7% | 0.01% | -7.7% |
Q3 2015 | $12,301,000 | – | 1,143,532 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |